Discover
INTS
Intensity Therapeutics, Inc.
4.40
1 x 4.00
1 x 4.55
bid
ask
-
0.30
6.38%
4 @ 04:00 PM
4.40 +0.00 (0.08%)
| Ytd | -57.12% | |
| 1y | -44.72% |
4.37
day range
4.75
3.51
52 week range
43.50
| Open | 4.62 | Prev Close | 4.70 | Low | 4.37 | High | 4.75 | Mkt Cap | 8.30M |
| Vol | 23.31K | Avg Vol | 41.93K | EPS | -2.84 | P/E | -1.55 | Forward P/E | -1.66 |
| Beta | 2.78 | Short Ratio | 3.05 | Inst. Own | 12.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 4.37 | 200-d Avg | 7.49 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 2.53M | ||
| Research and Development Expense | 1.20M | ||
| Selling, General and Administrative Expense | 1.33M | ||
| Operating Income | -2.53M | ||
| Net Income | -2.43M | ||
| Net Income Common Stock | -2.43M | ||
| Net Income Common Stock (USD) | -2.43M | ||
| Consolidated Income | -2.43M | ||
| Earnings per Basic Share | -0.96 | ||
| Earnings per Basic Share (USD) | -0.96 | ||
| Earnings per Diluted Share | -0.96 | ||
| Earning Before Interest & Taxes (EBIT) | -2.43M | ||
| Earning Before Interest & Taxes (USD) | -2.43M | ||
| Weighted Average Shares | 2.53M | ||
| Weighted Average Shares Diluted | 2.53M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.25M | ||
| Cash and Equivalents (USD) | 10.25M | ||
| Current Assets | 10.91M | ||
| Property, Plant & Equipment Net | 89.00K | ||
| Total Assets | 12.29M | ||
| Total Debt | 70.00K | ||
| Current Liabilities | 2.24M | ||
| Debt Non-Current | 70.00K | ||
| Total Liabilities | 2.31M | ||
| Accumulated Retained Earnings (Deficit) | -80.82M | ||
| Shareholders Equity | 9.98M | ||
| Shareholders Equity (USD) | 9.98M | ||
| Assets Non-Current | 1.39M | ||
| Total Debt (USD) | 70.00K | ||
| Liabilities Non-Current | 70.00K | ||
| Trade and Non-Trade Payables | 636.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.00K | ||
| Net Cash Flow from Financing | 150.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.68M | ||
| Issuance (Purchase) of Equity Shares | 150.00K | ||
| Net Cash Flow from Operations | -1.83M | ||
| Share Based Compensation | 387.00K | ||